New perspectives for TB treatment.

© 2011 par Sanofi Pasteur

© 2011 par Sanofi Pasteur

Pyrazinamide—Old TB Drug Finds New Target

More than 60 years after the discovery of pyrazinamide (PZA), a drug that is a mainstay of combination therapy for tuberculosis (TB), researchers have finally uncovered a mechanism of action that is convincing and novel. Stewart Cole (UPCOL - Chair of Microbial Pathogenesis ) comment (Science Perspective) on resent finding by Shi et al. showing that PZA inhibits trans-translation, a key cellular process for managing damaged proteins and “rescuing” nonfunctioning ribosomes, in Mycobacterium tuberculosis. The finding identifies a potentially promising target for new drugs.

Related Stories
Medicine / Pharmacology
Texting Made Possible for the Illiterate - 23.05Texting Made Possible for the Illiterate
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients - 17.05
Roche präsentiert beim ASCO-Kongress 2012 neue Daten zu wichtigen Entwicklungen für Patienten mit fortgeschrittenen Krebserkrankungen - 16.05
Les secrets d’une maladie orpheline dévoilés - 11.05Les secrets d'une maladie orpheline dévoilés
Eine Million für eine innovative Idee: Parasiten in der Sackgasse - 10.05Eine Million für eine innovative Idee: Parasiten in der Sackgasse
Leishmaniose : la Fondation Bill & Melinda Gates soutient des jeunes chercheuses de l’UNIL - 10.05Leishmaniose : la Fondation Bill & Melinda Gates soutient des jeunes cherche

Stewart T. Cole Science Vol. 333 no. 6049 pp. 1583-1584 (2011)

 
Logo Careerjet